A plain language summary of the phase 3 explorer7 study of concizumab prophylaxis for people with hemophilia with inhibitors
Open Access
- 19 February 2025
- journal article
- Published by Taylor & Francis in Future Rare Diseases
- Vol. 5 (1)
Abstract
No abstract availableFunding Information
- Novo Nordisk A/S, Denmark